Pediatric post-transplant metabolic syndrome: New clouds on the horizon

Pediatric Transplantation

Volumn 17, Issue 3, 2013, Pages 216-223

  Nobili, Valerio ^a   De Ville De Goyet, Jean ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

liver transplantation; pediatric; post transplant metabolic syndrome

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BONE DISEASE; CHILDHOOD OBESITY; DIABETES MELLITUS; DIET; DISEASE COURSE; DYSLIPIDEMIA; EXERCISE; FOLLOW UP; GRAFT SURVIVAL; KIDNEY DISEASE; LIFESTYLE MODIFICATION; LIVER TRANSPLANTATION; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OBESITY; POSTTRANSPLANT METABOLIC SYNDROME; RISK FACTOR; WEIGHT REDUCTION;

ADOLESCENT; CHILD; DIABETES COMPLICATIONS; DISEASE PROGRESSION; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; OBESITY; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84876697729     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12065     Document Type: Article

References (63)

1. Darwish AA, Bourdeaux C, Kader AH, et al. Pediatric liver transplantation using left hepatic segments from living related donors: Surgical experience in 100 recipients at Saint-Luc University Clinics. Pediatr Transpl 2006: 10: 345-353.
2. Nobili V, Dhawan A,. Are children after liver transplant more prone to non-alcoholic fatty liver disease? Pediatr Transplant 2008: 12: 611-613.
3. Satapathy SK, Charlton MR,. Posttransplant metabolic syndrome: New evidence of an epidemic and recommendations for management. Liver Transpl 2011: 17: 1-6.
4. Adeback P, Nemeth A, Fischler B,. Cognitive and emotional outcome after pediatric liver transplantation. Pediatr Transplant 2003: 7: 385-389.
5. Helenius I, Jalanko H, Remes V, et al. Scoliosis after solid organ transplantation in children and adolescents. Am J Transplant 2006: 6: 324-330.
6. Alonso EM,. Growth and developmental considerations in pediatric liver transplantation. Liver Transpl 2008: 14: 585-591.
7. Hogler W, Baumann U, Kelly D,. Growth and bone health in chronic liver disease and following liver transplantation in children. Pediatr Endocrinol Rev 2010: 7: 266-274.
8. Hogler W, Baumann U, Kelly D,. Endocrine and bone metabolic complications in chronic liver disease and after liver transplantation in children. J Pediatr Gastroenterol Nutr 2012: 54: 313-321.
9. Efstathiou SP, Skeva II, Zorbala E, Georgiou E, Mountokalakis TD,. Metabolic syndrome in adolescence. Circulation 2012: 125: 902-910.
10. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009: 119: 628-647.
11. Nobili V, Bedogni G, Berni Canani R, et al. The potential role of fatty liver in paediatric metabolic syndrome: A distinct phenotype with high metabolic risk? Pediatr Obes 2012: 7: e75-80.
12. Levy-Marchal C, Arslanian S, Cutfield W, et al.; ESPE-LWPES-ISPAD-APPES- APEG-SLEP-JSPE, Insulin Resistance in Children Consensus Conference Group. Insulin resistance in children: Consensus, perspective, and future directions. J Clin Endocrinol Metab 2010: 95: 5189-5198.
13. Perito ER, Lau A, Rhee S, Roberts JP, Rosenthal P,. Post-transplant metabolic syndrome in children and adolescents after liver transplant: A systematic review. Liver Transpl 2012: 18: 1009-1028.
14. Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving or 5 years after liver transplant. Transplantation 2000: 69: 781-789.
15. Tueche SG,. Diabetes mellitus after liver transplant: New etiologic clues and cornerstones for understanding. Transplant Proc 2003: 35: 1466-1468.
16. John PR, Thuluvath PJ,. Outcome of patients with new onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002: 8: 708-713.
17. Seo S, Maganti K, Khehra M, et al. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 2007: 13: 844-847.
18. Lim LG, Cheng CL, Wee A, et al. Prevalence and clinical associations of posttransplant fatty liver disease. Liver Int 2007: 27: 76-80.
19. Gane EJ,. Diabetes mellitus following liver transplantation in patients with hepatitis C virus: Risks and consequences. Am J Transplant 2012: 12: 531-538.
20. Hjelmesæth J, Åsberg A, Müller F, Hartmann A, Jenssen T,. New-onset posttransplantation diabetes mellitus: Insulin resistance or insulinopenia? Curr Diabetes Rev 2005: 1: 1-10.
21. Fort E, Mercadal G, Berlana D, et al. Diabetes mellitus associated with tacrolimus in renal transplant. Eur J Hosp Pharm Sci 2005: 11: 74-77.
22. Filler G, Neuschulz I, Vollmer I, Amendt P, Hocher B,. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. Nephrol Dial Transplant 2000: 15: 867-871.
23. Goldberg PA,. Comprehensive management of post-transplant diabetes mellitus: From intensive care to home care. Endocrinol Metab Clin North Am 2007: 36: 907-922.
24. Siirtola A, Antikainen M, Ala-Houhala M, et al. Serum lipids in children 3 to 5 years after kidney, liver, and heart transplantation. Transpl Int 2004: 17: 109-119.
25. Fernandez-Miranda C, De La Calle A, Morales JM, et al. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. Clin Transplant 1998: 12: 136-141.
26. Munoz SJ,. Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: Pathogenesis, diagnosis and management. Liver Transpl Surg 1995: 1 (suppl 1): 29-38.
27. Trotter JF, Wachs ME, Trouillot TE, et al. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. Liver Transpl 2001: 7: 401-408.
28. East C, Grundy SM, Bilheimer DW,. Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation. JAMA 1986: 256: 2843-2848.
29. Gazi IF, Liberopoulos EN, Athyros VG, Elisaf M, Mikhailidis DP,. Statins and solid organ transplantation. Curr Pharm Des 2006: 12: 4771-4783.
30. Zachoval R, Gerbes AL, Schwandt P, Parhofer KG,. Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: Results of a randomized cross-over trial. J Hepatol 2001: 35: 86-91.
31. National Kidney Foundation. K/DOQI clinical practice guidelines on managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 2003: 41 (Suppl 3): S1-S92.
32. KDOQI Work Group. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 2009: 3 (Suppl 2): S11-S104.
33. Burke A,. Medical management of the liver transplant patient. Graft 2003: 6: 136.
34. Kotur-Stevuljevic̈ J, Peco-Antic̈ A, Spasic̈ S, et al. Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease. Pediatr Nephrol 2013: 28: 295-303.
35. Neal DA, Gimson AE, Gibbs P, Alexander GJ,. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Liver Transpl 2001: 7: 533-539.
36. Albeldawi M, Aggarwal A, Madhwal S, et al. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl 2012: 18: 370-375.
37. Sundaram SS, Alonso EM, Zeitler P, Yin W, Anand R, THE SPLIT RESEARCH GROUP. Obesity after pediatric liver transplantation: Prevalence and risk factors. J Pediatr Gastroenterol Nutr 2012; 55: 657-662.
38. Laryea M, Watt KD, Molinari M, et al. Metabolic syndrome in liver recipients: Prevalence and association with major vascular events. Liver Transpl 2007: 13: 1109-1114.
39. Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ,. Posttransplant metabolic syndrome: An epidemic waiting to happen. Liver Transpl 2009: 15: 1662-1670.
40. Dick A, Perkins JD, Spitzer AL, Lao OB, Healey PJ, Reyes JD,. Impact of obesity on children undergoing liver transplantation. Liver Transpl 2010: 16: 1296-1302.
41. Wilson AC, Greenbaum LA, Barletta GM, et al. High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients. Pediatr Transplant 2010: 14: 52-60.
42. WHO Library Cataloguing-in-Publication Data World Health Organization. Global strategy on diet, physical activity and health. ISBN 92 4 159222 2 (LC/NLM classification: QT 180). Available at: http://www.who.int/ dietphysicalactivity/en. (Accessed July 2010).
43. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM,. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006: 295: 1549-1555.
44. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C,. Prevalence of fatty liver in children and adolescents. Pediatrics 2006: 118: 1388-1393.
45. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA,. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011: 141: 1249-1253.
46. Dureja P, Mellinger J, Agni R, et al. NAFLD recurrence in liver transplant recipients. Transplantation 2011: 91: 684-689.
47. Dick AA, Spitzer AL, Seifert CF, et al. Liver transplantation at the extremes of body mass index. Liver Transpl 2009: 15: 968-977.
48. Flancbaum L, Choban PS,. Surgical implications of obesity. Annu Rev Med 1998: 49: 215-234.
49. Choban PS, Flancbaum L,. The impact of obesity on surgical outcomes: A review. J Am Coll Surg 1997: 185: 593-603.
50. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P,. The natural history of non-alcoholic fatty liver disease in children: A follow-up study for up to 20 years. Gut 2009: 58: 1538-1544.
51. Ode KL, Frohnert BI, Nathan BM,. Identification and treatment of metabolic complications in pediatric obesity. Rev Endocr Metab Disord 2009: 10: 167-188.
52. Rosenbloom AL, Joe JR, Young RS, Winter WE,. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999: 22: 345-354.
53. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002: 346: 802-810.
54. Freedman DS, Khan LK, Serdula MK, Dietz WH, Sriinivasan SR, Berenson GS,. The relation of childhood BMI to adult adiposity: The Bogalusa Heart Study. Pediatrics 2005: 115: 22-27.
55. Li D, Morris JS, Liu J, et al. Body mass index and risk, age of onset and survival in patients with pancreatic cancer. JAMA 2009: 301: 2553-2562.
56. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: Concerns and recommendations. Pediatrics 2004: 114: 217-223.
57. Guasch A, Bullõ M, Rabassa A, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: A cross-sectional study. Cardiovasc Diabetol 2012: 11: 149.
58. Compston JE,. Hepatic osteodystrophy: Vitamin D metabolism in patients with liver disease. Gut 1986: 27: 1073-1090.
59. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001: 24: 683-689.
60. Caballero EA,. Endothelial dysfunction in obesity and insulin resistance: A road to diabetes and heart disease. Obes Res 2003: 11: 1278-1289.
61. Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 2008: 29: 777-822.
62. Guimarães GV, D'Avila VM, Chizzola PR, Bacal F, Stolf N, Bocchi EA,. Physical rehabilitation in heart transplantation. Rev Bras Med Esporte 2004: 10: 412-415.
63. Ward HJ,. Nutritional and metabolic issues in solid organ transplantation: Targets for future research. J Ren Nutr 2009: 19: 111-122.